IBDEI3FY ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,57892,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,57892,1,2,0)
 ;;=2^92228
 ;;^UTILITY(U,$J,358.3,57892,1,3,0)
 ;;=3^REMOTE IMAGING-RETINAL MGMT
 ;;^UTILITY(U,$J,358.3,57893,0)
 ;;=92250^^271^2899^1^^^^1
 ;;^UTILITY(U,$J,358.3,57893,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,57893,1,2,0)
 ;;=2^92250
 ;;^UTILITY(U,$J,358.3,57893,1,3,0)
 ;;=3^FUNDUS PHOTO W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,57894,0)
 ;;=T1014^^271^2899^6^^^^1
 ;;^UTILITY(U,$J,358.3,57894,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,57894,1,2,0)
 ;;=2^T1014
 ;;^UTILITY(U,$J,358.3,57894,1,3,0)
 ;;=3^TELEHEALTH TRANSMIT, PER MIN
 ;;^UTILITY(U,$J,358.3,57895,0)
 ;;=3072F^^271^2899^2^^^^1
 ;;^UTILITY(U,$J,358.3,57895,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,57895,1,2,0)
 ;;=2^3072F
 ;;^UTILITY(U,$J,358.3,57895,1,3,0)
 ;;=3^LOW RISK FOR RETINOPATHY
 ;;^UTILITY(U,$J,358.3,57896,0)
 ;;=B02.33^^272^2900^161
 ;;^UTILITY(U,$J,358.3,57896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57896,1,3,0)
 ;;=3^Zoster Keratitis
 ;;^UTILITY(U,$J,358.3,57896,1,4,0)
 ;;=4^B02.33
 ;;^UTILITY(U,$J,358.3,57896,2)
 ;;=^5000496
 ;;^UTILITY(U,$J,358.3,57897,0)
 ;;=B02.32^^272^2900^160
 ;;^UTILITY(U,$J,358.3,57897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57897,1,3,0)
 ;;=3^Zoster Iridocyclitis
 ;;^UTILITY(U,$J,358.3,57897,1,4,0)
 ;;=4^B02.32
 ;;^UTILITY(U,$J,358.3,57897,2)
 ;;=^5000495
 ;;^UTILITY(U,$J,358.3,57898,0)
 ;;=B00.52^^272^2900^82
 ;;^UTILITY(U,$J,358.3,57898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57898,1,3,0)
 ;;=3^Herpesviral Keratitis
 ;;^UTILITY(U,$J,358.3,57898,1,4,0)
 ;;=4^B00.52
 ;;^UTILITY(U,$J,358.3,57898,2)
 ;;=^5000474
 ;;^UTILITY(U,$J,358.3,57899,0)
 ;;=B00.51^^272^2900^81
 ;;^UTILITY(U,$J,358.3,57899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57899,1,3,0)
 ;;=3^Herpesviral Iridocyclitis
 ;;^UTILITY(U,$J,358.3,57899,1,4,0)
 ;;=4^B00.51
 ;;^UTILITY(U,$J,358.3,57899,2)
 ;;=^5000473
 ;;^UTILITY(U,$J,358.3,57900,0)
 ;;=B30.8^^272^2900^47
 ;;^UTILITY(U,$J,358.3,57900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57900,1,3,0)
 ;;=3^Conjunctivitis,Viral NEC
 ;;^UTILITY(U,$J,358.3,57900,1,4,0)
 ;;=4^B30.8
 ;;^UTILITY(U,$J,358.3,57900,2)
 ;;=^88239
 ;;^UTILITY(U,$J,358.3,57901,0)
 ;;=C69.41^^272^2900^113
 ;;^UTILITY(U,$J,358.3,57901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57901,1,3,0)
 ;;=3^Malig Neop of Right Ciliary Body
 ;;^UTILITY(U,$J,358.3,57901,1,4,0)
 ;;=4^C69.41
 ;;^UTILITY(U,$J,358.3,57901,2)
 ;;=^5001279
 ;;^UTILITY(U,$J,358.3,57902,0)
 ;;=C69.42^^272^2900^111
 ;;^UTILITY(U,$J,358.3,57902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57902,1,3,0)
 ;;=3^Malig Neop of Left Ciliary Body
 ;;^UTILITY(U,$J,358.3,57902,1,4,0)
 ;;=4^C69.42
 ;;^UTILITY(U,$J,358.3,57902,2)
 ;;=^5001280
 ;;^UTILITY(U,$J,358.3,57903,0)
 ;;=C69.01^^272^2900^114
 ;;^UTILITY(U,$J,358.3,57903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57903,1,3,0)
 ;;=3^Malig Neop of Right Conjunctiva
 ;;^UTILITY(U,$J,358.3,57903,1,4,0)
 ;;=4^C69.01
 ;;^UTILITY(U,$J,358.3,57903,2)
 ;;=^5001267
 ;;^UTILITY(U,$J,358.3,57904,0)
 ;;=C69.02^^272^2900^112
 ;;^UTILITY(U,$J,358.3,57904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57904,1,3,0)
 ;;=3^Malig Neop of Left Conjunctiva
 ;;^UTILITY(U,$J,358.3,57904,1,4,0)
 ;;=4^C69.02
 ;;^UTILITY(U,$J,358.3,57904,2)
 ;;=^5001268
 ;;^UTILITY(U,$J,358.3,57905,0)
 ;;=D31.41^^272^2900^17
 ;;^UTILITY(U,$J,358.3,57905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57905,1,3,0)
 ;;=3^Benign Neop of Right Ciliary Body
 ;;^UTILITY(U,$J,358.3,57905,1,4,0)
 ;;=4^D31.41
 ;;^UTILITY(U,$J,358.3,57905,2)
 ;;=^5002124
